The Cigna Group (CI) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CI SEC filings page.
The Cigna Group (CI) reported $282.4B in revenue over the twelve months to Jun 30, 2026, up 7.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale expanded, but thin operating margins and shareholder distributions increasingly shape how the business uses its cash.
Revenue expanded11.2% in FY2025, yet operating income declined to$9.2B , indicating that added scale did not translate proportionally into operating earnings. Net income recovered while operating cash flow fell7.3% from FY2024, suggesting the earnings rebound was less cash-supported than the headline profit change; margins also remained in a narrow, low-single-digit band across the period.
Current liabilities exceeded current assets by
Share count fell
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of The Cigna Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
The Cigna Group has an operating margin of 3.4%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 57/100, indicating healthy but not exceptional operating efficiency. This is down from 3.8% the prior year.
The Cigna Group's revenue grew 11.2% year-over-year to $274.9B, a solid pace of expansion. This earns a growth score of 80/100.
The Cigna Group has a moderate D/E ratio of 0.74. This balance of debt and equity financing earns a leverage score of 32/100.
The Cigna Group's current ratio of 0.85 is below the typical benchmark, resulting in a score of 13/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Not available for The Cigna Group, and counted as zero in the overall score.
The Cigna Group earns a strong 14.3% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 72/100. This is up from 8.4% the prior year.
The Cigna Group scores 2.66, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
The Cigna Group passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, The Cigna Group generates $1.61 in operating cash flow ($9.6B OCF vs $6.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
The Cigna Group earns $6.57 in operating income for every $1 of interest expense ($9.2B vs $1.4B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
The Cigna Group generated $71.7B in revenue in Q2 2026. This represents an increase of 6.7% from the same quarter a year earlier. Against the prior quarter it is up 4.6%.
The Cigna Group's EBITDA was $3.3B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.5% from the same quarter a year earlier. Against the prior quarter it is up 10.7%.
The Cigna Group reported $1.7B in net income in Q2 2026. This represents an increase of 8.4% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.
The Cigna Group earned $6.29 per diluted share (EPS) in Q2 2026. This represents an increase of 10.2% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.
Cash & Balance Sheet
The Cigna Group held $6.3B in cash against $29.1B in long-term debt as of Q2 2026.
The Cigna Group paid $1.56 per share in dividends in Q2 2026. This represents an increase of 3.3% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Margins & Returns
The Cigna Group's operating margin was 3.7% in Q2 2026, reflecting core business profitability. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
The Cigna Group's net profit margin was 2.3% in Q2 2026, showing the share of revenue converted to profit. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
The Cigna Group's ROE was 3.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Capital Allocation
The Cigna Group spent $280.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 74.8% from the same quarter a year earlier.
Not reported for Q2 2026.
Not reported for Q2 2026.
CI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.7B+6.7% | $68.5B+4.6% | $72.5B+10.4% | $69.7B+9.5% | $67.2B+11.0% | $65.5B+14.4% | $65.6B+28.4% | $63.7B+29.9% |
| Cost of Revenue | $56.7B+6.4% | $54.1B+11.8% | $57.8B+17.9% | $55.5B+16.7% | $53.3B+19.7% | $48.4B+16.8% | $49.0B+39.0% | $47.6B+41.4% |
| SG&A Expenses | $3.5B+1.1% | $3.7B-11.7% | $3.6B-6.6% | $3.4B-6.4% | $3.4B-6.8% | $4.2B+13.7% | $3.9B-4.8% | $3.6B-5.2% |
| Operating Income | $2.7B+16.0% | $2.4B+19.6% | $2.3B+7.9% | $2.6B+0.1% | $2.3B-4.4% | $2.0B-12.6% | $2.2B+5.5% | $2.6B+15.0% |
| EBITDA | $3.3B+11.5% | $3.0B+13.7% | $3.1B+8.8% | $3.3B+1.5% | $3.0B-5.1% | $2.6B-11.7% | $2.8B-0.2% | $3.2B+7.3% |
| Interest Expense | $359.0M+6.2% | $357.0M-1.4% | $337.0M-9.7% | $363.0M-4.5% | $338.0M-10.6% | $362.0M-1.9% | $373.0M+6.0% | $380.0M+7.6% |
| Income Tax | $382.0M-1.8% | $409.0M+71.1% | $543.0M+14.8% | $322.0M-12.3% | $389.0M+8.1% | $239.0M-17.9% | $473.0M+151.5% | $367.0M-6.1% |
| Net Income | $1.7B+8.4% | $1.7B+25.0% | $1.1B-5.3% | $2.0B+139.2% | $1.5B-6.0% | $1.3B+724.1% | $1.2B+32.6% | $825.0M-43.1% |
| EPS (Basic) | $6.31+9.5% | $6.30+29.1% | $4.68-8.6% | $7.02+164.9% | $5.76+4.5% | $4.88+603.1% | $5.12+44.6% | $2.65-44.7% |
| EPS (Diluted) | $6.29+10.2% | $6.26+29.1% | $4.66-8.1% | $6.98+165.4% | $5.71+4.8% | $4.85+600.0% | $5.07+44.9% | $2.63-44.5% |
| Diluted Shares (Avg) | 264M-1.6% | 264M-3.3% | N/A | 268M-4.9% | 268M-5.6% | 273M-4.7% | N/A | 281M-5.3% |
Not reported in any period shown, so not listed: Gross Profit, R&D Expenses.
CI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $157.1B+3.6% | $153.3B+1.7% | $157.9B+1.3% | $157.9B+0.2% | $151.7B-2.4% | $150.7B-1.6% | $155.9B+2.0% | $157.6B+5.3% |
| Current Assets | $47.0B+5.1% | $43.0B-1.2% | $47.8B-2.2% | $46.7B-5.1% | $44.7B-3.2% | $43.6B+0.5% | $48.9B+30.8% | $49.2B+42.6% |
| Cash & Equivalents | $6.3B+45.5% | $7.0B-15.5% | $7.7B+1.7% | $6.0B+2.3% | $4.3B-36.2% | $8.3B-1.2% | $7.5B-3.5% | $5.9B-30.7% |
| Short-Term Investments | $959.0M+18.0% | $812.0M+11.7% | $1.1B+58.8% | $883.0M+2.2% | $813.0M-23.9% | $727.0M-34.4% | $665.0M-28.1% | $864.0M-17.4% |
| Inventory | $5.8B-2.0% | $5.8B+12.7% | $7.3B+9.7% | $5.6B+10.8% | $6.0B+15.3% | $5.2B+11.8% | $6.7B+18.5% | $5.1B+15.1% |
| Long-Term Investments | $5.2B+8.6% | $5.2B+10.1% | $5.0B-66.7% | $4.9B-68.0% | $4.8B-69.7% | $4.7B-70.8% | $15.1B-15.9% | $15.3B+274.6% |
| Goodwill | $45.5B+2.6% | $45.5B+2.6% | $44.9B+1.2% | $44.9B+1.2% | $44.4B+0.3% | $44.4B+0.3% | $44.4B+0.3% | $44.4B-3.1% |
| Total Liabilities | $114.2B+2.7% | $110.8B+0.5% | $116.0B+1.2% | $115.9B+0.5% | $111.2B-2.4% | $110.2B-1.4% | $114.6B+7.7% | $115.3B+11.0% |
| Current Liabilities | $55.6B-2.1% | $52.6B-5.6% | $56.3B-2.8% | $56.5B-1.1% | $56.8B+2.5% | $55.7B+7.2% | $58.0B+19.0% | $57.1B+21.3% |
| Non-Current Liabilities | $58.6B+7.7% | $58.2B+6.8% | $59.7B+5.4% | $59.5B+2.0% | $54.4B-7.0% | $54.5B-8.9% | $56.7B-1.8% | $58.3B+2.6% |
| Long-Term Debt | $29.1B+9.8% | $29.4B+11.0% | $30.9B+6.7% | $30.9B+2.4% | $26.5B-12.2% | $26.5B-14.8% | $28.9B+2.8% | $30.2B+7.6% |
| Total Equity | $42.6B+6.0% | $42.2B+4.9% | $41.7B+1.7% | $41.8B-0.7% | $40.2B-2.7% | $40.2B-2.3% | $41.0B-11.2% | $42.1B-7.9% |
| Retained Earnings | $50.4B+10.5% | $49.1B+10.5% | $47.9B+10.0% | $47.0B+10.7% | $45.6B+8.1% | $44.4B+8.4% | $43.5B+4.5% | $42.5B+3.7% |
Not reported in any period shown, so not listed: Accounts Receivable.
CI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$421.0M+77.7% | $1.1B-41.1% | $6.1B+18.0% | $3.4B+7330.4% | -$1.9B-811.7% | $1.9B-60.3% | $5.2B+255.3% | $46.0M-98.4% |
| Depreciation & Amortization | $655.0M-4.0% | $650.0M-3.6% | $722.0M+11.8% | $697.0M+7.2% | $682.0M-7.6% | $674.0M-9.0% | $646.0M-15.6% | $650.0M-15.1% |
| Investing Cash Flow | -$503.0M+36.9% | -$637.0M-153.2% | -$420.0M-119.9% | -$4.4B-465.3% | -$797.0M-24.5% | $1.2B+341.8% | -$191.0M+56.6% | -$776.0M+42.0% |
| Financing Cash Flow | $207.0M+115.5% | -$1.1B+69.0% | -$4.1B-25.2% | $2.7B+505.7% | -$1.3B+42.3% | -$3.7B-45.6% | -$3.2B-159.8% | $439.0M+117.1% |
| Dividends Paid | $409.0M+2.0% | $417.0M+1.2% | $396.0M+3.1% | $402.0M+3.1% | $401.0M+2.3% | $412.0M+2.7% | $384.0M+7.3% | $390.0M+7.7% |
| Share Buybacks | $280.0M-74.8% | $0-100.0% | $1.0B-50.5% | $0 | $1.1B+12.3% | $1.5B-62.5% | $2.0B+271.7% | $0-100.0% |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.
CI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7%+0.3pp | 3.4%+0.4pp | 3.2%-0.1pp | 3.7%-0.3pp | 3.4%-0.6pp | 3.0%-0.9pp | 3.3%-0.7pp | 4.0%-0.5pp |
| Net Margin | 2.3%0.0pp | 2.4%+0.4pp | 1.6%-0.3pp | 2.8%+1.5pp | 2.3%-0.4pp | 2.0%+2.4pp | 1.8%+0.1pp | 1.3%-1.7pp |
| Return on Equity | 3.9%+0.1pp | 3.9%+0.6pp | 2.7%-0.2pp | 4.7%+2.8pp | 3.8%-0.1pp | 3.3%+3.8pp | 2.9%+1.0pp | 2.0%-1.2pp |
| Return on Assets | 1.1%+0.1pp | 1.1%+0.2pp | 0.7%0.0pp | 1.3%+0.7pp | 1.0%0.0pp | 0.9%+1.0pp | 0.8%+0.2pp | 0.5%-0.5pp |
| Current Ratio | 0.85+0.1x | 0.820.0x | 0.850.0x | 0.830.0x | 0.790.0x | 0.78-0.1x | 0.84+0.1x | 0.86+0.1x |
| Debt-to-Equity | 0.680.0x | 0.700.0x | 0.740.0x | 0.740.0x | 0.66-0.1x | 0.66-0.1x | 0.71+0.1x | 0.72+0.1x |
| Asset Turnover | 0.460.0x | 0.450.0x | 0.460.0x | 0.440.0x | 0.44+0.1x | 0.43+0.1x | 0.42+0.1x | 0.40+0.1x |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.85), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| The Cigna Group CI | FY2025 | $274.9B | $6.0B | 2.2% | $71.5B | 42/100 |
| CVS Health Corporation CVS | FY2025 | $402.1B | $1.8B | 0.4% | $109.0B | 35/100 |
| Elevance Health, Inc. ELV | FY2025 | $199.1B | $5.7B | 2.8% | $82.8B | 49/100 |
| Humana Inc. HUM | FY2025 | $129.7B | $1.2B | 0.9% | $45.6B | 50/100 |
| Centene Corporation CNC | FY2025 | $194.8B | -$6.7B | -3.4% | $30.1B | 36/100 |
| Molina Healthcare, Inc. MOH | FY2025 | $45.4B | $472.0M | 1.0% | $9.4B | 63/100 |
Where The Cigna Group Ranks
Frequently Asked Questions
What is The Cigna Group's annual revenue?
The Cigna Group (CI) reported $274.9B in total revenue for fiscal year 2025. This represents a 11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is The Cigna Group's revenue growing?
The Cigna Group (CI) revenue grew by 11.2% year-over-year, from $247.1B to $274.9B in fiscal year 2025.
Is The Cigna Group profitable?
Yes, The Cigna Group (CI) reported a net income of $6.0B in fiscal year 2025, with a net profit margin of 2.2%.
What is The Cigna Group's EBITDA?
The Cigna Group (CI) had EBITDA of $12.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does The Cigna Group have?
As of fiscal year 2025, The Cigna Group (CI) had $7.7B in cash and equivalents against $30.9B in long-term debt.
What is The Cigna Group's operating margin?
The Cigna Group (CI) had an operating margin of 3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is The Cigna Group's net profit margin?
The Cigna Group (CI) had a net profit margin of 2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does The Cigna Group pay dividends?
Yes, The Cigna Group (CI) paid $6.04 per share in dividends during fiscal year 2025.
What is The Cigna Group's return on equity (ROE)?
The Cigna Group (CI) has a return on equity of 14.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is The Cigna Group's operating cash flow?
The Cigna Group (CI) generated $9.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are The Cigna Group's total assets?
The Cigna Group (CI) had $157.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What is The Cigna Group's current ratio?
The Cigna Group (CI) had a current ratio of 0.85 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is The Cigna Group's debt-to-equity ratio?
The Cigna Group (CI) had a debt-to-equity ratio of 0.74 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is The Cigna Group's return on assets (ROA)?
The Cigna Group (CI) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is The Cigna Group's P/E ratio?
The Cigna Group (CI) trades at 11.1x earnings, its market capitalization divided by net income of $6.4B net income, trailing 12 months to June 30, 2026. The market capitalization is $71.5B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is The Cigna Group's price-to-sales ratio?
The Cigna Group (CI) trades at 0.3x sales, its market capitalization divided by revenue of $282.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $71.5B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is The Cigna Group's Altman Z-Score?
The Cigna Group (CI) has an Altman Z-Score of 2.66, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is The Cigna Group's Piotroski F-Score?
The Cigna Group (CI) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are The Cigna Group's earnings high quality?
The Cigna Group (CI) has an earnings quality ratio of 1.61x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can The Cigna Group cover its interest payments?
The Cigna Group (CI) has an interest coverage ratio of 6.57x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is The Cigna Group?
The Cigna Group (CI) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.